Invitrogen Will Co-Promote Its Imaging Reagents With Mauna Kea's Instruments | GenomeWeb
NEW YORK (GenomeWeb News) — In vivo cellular-imaging company Mauna Kea Technologies will jointly promote its instruments with Invitrogen reagents.
 
Mauna Kea, headquartered both in Paris and Cambridge, Mass., said the combination of its fluorescent fiber optic microscopy with fluorescent reagents made by Invitrogen division Molecular Probes will allow customers to generate target images in living animals.   
 
Invitrogen said the pairing anticipates greater demand for molecular imaging.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.